The vaccine trial of AstraZeneca against coronavirus in children in the UK has been stopped, while regulators are investigating reports of blood clots among adults immunized with the drug. The University of Oxford said the study did not raise safety concerns. But he is waiting for more information from the Agency for Regulation of Medicines and Health Products before continuing with vaccinations, independent.ie reported.
Regulators from the United Kingdom, Europe and the World Health Organization (WHO) are evaluating the data. The WHO and the European Medicines Agency (EMA) have confirmed that they will publish the findings later this week.
The EMA has not yet concluded whether the AstraZeneca vaccine causes thrombosis
A press conference is expected on Wednesday or Thursday
–
The University of Oxford said in a statement: “Although there are no safety concerns in the pediatric clinical trial, we expect additional information before giving additional vaccinations in the process. Parents and children can contact us if they have any questions.”
To date, none of the Covid vaccines approved for use in adults, is not approved for children, and studies in children are just beginning.
The European Medicines Agency (EMA) has announced that it has not yet been concluded whether the AstraZeneca vaccine causes thrombosis. Dr. Marco Cavaleri, chairman of the European Medicines Agency’s working group on COVID-19, told an Italian newspaper that the vaccine is associated with thrombosis.
In mid-March, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) decided that AstraZeneca vaccine is “safe and effective” and the benefits outweigh the possible risks. The vaccine was then reported not to be associated with an increased overall risk of thromboembolism or blood clots.
A number of European countries have temporarily stopped the vaccine due to cases of thromboembolism, and most have subsequently resumed the vaccine, but only in people over 60 years of age.
The Austrian health authorities were the first to stop using the batchafter a 49-year-old woman died of multiple thrombosis 10 days after vaccination.
